Singapore scientists deliberately infect volunteers with COVID-19 to speed up vaccine development
NCT ID NCT06654973
First seen Jan 12, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study aims to safely infect up to 20 healthy adults aged 21-30 with the Delta variant of SARS-CoV-2 using nasal drops. The goal is to create a controlled human infection model in Singapore that can be used to test new vaccines and treatments faster. Participants are closely monitored for safety and infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Centre for Infectious Diseases
Singapore, Singapore, 308442, Singapore
Conditions
Explore the condition pages connected to this study.